Cologne Scientists Reveal How Leucine Supercharges Mitochondria by Silencing a Cellular Shredder

A team of cell biologists at the University of Cologne has identified a strikingly direct mechanism by which leucine — an essential amino acid found in protein-rich foods such as beef, fish, eggs, dairy and soy — supercharges the energy-producing machinery inside human cells. Reporting in Nature Cell Biology on May 20, the researchers show that leucine works not by serving as a fuel itself, but by silencing a molecular shredder that would otherwise destroy the proteins mitochondria rely on to generate ATP, the universal currency of cellular energy.

The central player is a protein called SEL1L, which sits in the membrane of the endoplasmic reticulum and helps mark damaged or misfolded proteins for destruction. The Cologne team, led by Aleksandra Trifunovic of the Institute for Mitochondrial Diseases and Ageing, showed that leucine binds and suppresses SEL1L's degradation activity at the outer mitochondrial membrane. With SEL1L throttled back, the proteins that import metabolites and assemble the electron-transport chain accumulate at higher levels, mitochondria fire more efficiently, and cells respond to high-demand conditions — exercise, fasting, oxidative stress — by ramping up energy output rather than stalling.

"What surprised us was how specific the effect is," Trifunovic said in a statement released by the university. "Leucine does not work like a general nutrient signal. It pulls one particular brake off one particular degradation pathway, and that is enough to retune the whole organelle." The team confirmed the effect in human cell lines and in mouse muscle and liver tissue, and showed that the mechanism is conserved across species — strong evidence that it represents a fundamental piece of mammalian energy biology that had been hiding in plain sight.

The medical implications are potentially substantial. Disrupted leucine metabolism showed up in the team's screens in two very different disease contexts: impaired mitochondrial function and reduced fertility in animal models, and an unusual class of mutations the researchers identified in human lung-cancer cells, where rogue activation of the leucine–SEL1L axis appears to help tumor cells survive metabolic stress. "This gives us a target," said co-author David Pla-Martín. "If you can disrupt the leucine signal selectively in tumors while preserving it in healthy tissue, you may be able to starve cancers of an adaptive advantage they have been quietly using."

The study lands in the middle of a long-running scientific argument over whether leucine supplementation — popular for decades in bodybuilding and clinical-nutrition circles — actually does anything beyond providing raw amino-acid building blocks. Independent commentators were cautious but intrigued. "This is the kind of mechanistic clarity that has been missing," said Stuart Phillips, a McMaster University muscle metabolism researcher who was not involved in the study. "It does not yet tell us the right dose for a person, or whether eating extra leucine is meaningfully better than just eating enough total protein, but it tells us why leucine kept showing up in the data when other amino acids did not." Trifunovic's group is now working with the Max Planck Institute for Biology of Ageing to test whether targeted leucine signaling can extend healthspan in older mice.